Navigation Links
Revamped Therapies Preventing Visual Impairment Primed to Revolutionize US Retinal Therapeutics Market
Date:1/8/2014

MOUNTAIN VIEW, Calif., Jan. 8, 2014 /PRNewswire/ -- The need for effective and patient-friendly treatment of retinal diseases to avoid visual impairment is driving the retinal therapeutics market in the U.S. Vascular endothelial growth factor (VEGF) inhibitors dominate the market as they are a safe and effective option to treat age-related macular degeneration (AMD), diabetic macular edema (DME), and retinal vein occlusion (RVO). Although highly efficacious, existing VEGF treatments require frequent, invasive intravitreal injections. Thus, growth opportunities exist for new therapies with comparable efficacy but improved dosing and administration.

New analysis from Frost & Sullivan's (http://www.lifesciences.frost.com) Analysis of the US Retinal Therapeutics Market finds the market earned revenue of $2.45 billion in 2012 and estimates this to almost double to $4.15 billion in 2017.

For more information on this research, please email Jennifer Carson, Corporate Communications, at jennifer.carson@frost.com, with your full name, company name, job title, telephone number, company email address, company website, city, state and country.

"Despite the popularity of VEGF inhibitors in the U.S., issues of patient preference and compliance, the risk of infection, as well as side effects such as floaters, increased intraocular pressure and inflammation of the eye exist," said Frost & Sullivan Life Sciences Senior Industry Analyst Debbie Toscano. "There is also a lack of substantive long term data on the ability of VEGF therapy to prevent visual impairment."

In addition, the rapid uptake of low-cost Avastin, supplied by compounding pharmacies, is challenging the VEGF inhibitors market. Although the U.S. Food and Drug Administration has drawn attention to safe
'/>"/>

SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Intra-Cellular Therapies Cleared for Quotation on OTCQB
2. Immunotherapies Will Continue to Dominate the Malignant Melanoma Drug Market with Sales of Immune Checkpoint Inhibitors Accounting for Majority of Sales in this Drug Class in 2022
3. The Leukemia & Lymphoma Societys (LLS) Greater Bay Area Chapter to Host the 2014 Emerging Therapies & Survivorship Conference
4. Sangamo BioSciences Presents Data From Non-Human Primates Providing Proof Of Concept For Disruptive And Broadly Leverageable Platform For Protein Replacement Therapies
5. Improved Efficacy, Limited Toxicity of Targeted Therapies Brighten the Future of Treatment for Chronic Lymphocytic Leukemia
6. Innovative Compounds, Combination Therapies Improve Care of Patients with Wide Range of Blood Disorders
7. Study Confirms Efficacy of Innovative Therapies Quantum Negative Pressure Wound Therapy (NPWT) in Enhancing Wound Healing
8. Contrasting Reimbursement Environments Result in Different Prescribing Patterns for Premium-Priced Therapies in China and South Korea
9. U.S. Claims Data Show Declining Use of Platform Injectables as Oral Multiple Sclerosis Therapies Gain Traction
10. In the Psoriasis Drug Market, Continued Uptake of Janssens Stelara and the Launch of Emerging Systemic Therapies Will Drive Sales Growth to Nearly $9.2 Billion in 2022
11. Among Newly Diagnosed Type 2 Diabetes Patients, DPP-IV Inhibitors are the Leading Oral Therapies After Standard Metformin and Sulfonylurea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... Tobago , July 25, 2014  The ... & Tobago Ministry of Health approved the introduction ... significantly increases the cure rate from Hepatitis C, ... the genotype 1 virus. Telaprevir is available in ... brand INCIVO®. Photo - http://www2.prnewswire.com.br/imgs/pub/2014-07-25/original/2026.jpg ...
(Date:7/25/2014)...  Acsis Inc., the market leader for supply ... recently posted an article, "Future of Running ... needs for companies, extended supply chain, and explains ... no longer work today.  The article explains how ... mobile technology, machine to machine (M2M) connectivity, and ...
(Date:7/25/2014)... 25, 2014 According to a ... and China Insulin Market (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, Premixed, ... Growth, Trends and Forecast (Value and Volume), 2013 - ... 19.99 billion in 2012 and is expected to grow ... to reach USD 32.24 billion in 2019. ...
Breaking Medicine Technology:The Hepatitis C virus is the main cause of liver transplant in the world 2The Hepatitis C virus is the main cause of liver transplant in the world 3Acsis Addresses Questions on the Modern Supply Chain 2Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 2Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 3Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 4
... MOUNTAIN VIEW, Calif. , July 29 IRIDEX Corporation (Nasdaq: IRIX ... the market closes on Thursday, August 5, 2010 . ... investment community at 5:00 p.m. Eastern Time on ... of the quarter and other business developments. , ...
... SAVANNAH, Ga. , July 29 MIT Holding, Inc. announces ... of the board of directors. MIT Holding, Inc. founder William "Rocky" Parker ... , , , ... being the senior managing director of Drakeford & Drakeford for the past ...
Cached Medicine Technology:IRIDEX Announces Second Quarter 2010 Conference Call and Release Date 2Walter H.C. Drakeford Named Co-President and Co-Chairman of the Board of Directors for MIT Holding, Inc. 2
(Date:7/26/2014)... Studio B Dental in Toronto now offers All-on-Four dental ... a Day, gives patients the opportunity to replace their damaged ... whites with very little recovery time and no bone grafting. ... like natural teeth, and require no special care beyond the ... is one of the premiere dental experts on All-on-Four implants ...
(Date:7/26/2014)... According to the Banish My Bumps Pdf review ... that covers detailed instructions on how to eliminate ... any medication. , Vkool reveals in its review ... for relieving symptoms of keratosis pilaris quickly. In addition, ...     How to treat children's keratosis pilaris ,     How ...
(Date:7/25/2014)... (PRWEB) July 26, 2014 PersonalInjurySolicitorsIreland, ... legal help to people who have suffered from ... launch of both their new company, and a ... on the new website explained, http://www.personalinjurysolicitorsireland.com/personal-injury-claims , ... The focus of the company is always on ...
(Date:7/25/2014)... TX (PRWEB) July 25, 2014 American ... accidents or unexpected collisions can pay higher premiums for ... enhanced its local insurer network to provide SR22 insurance ... . , The different coverage network of local ... has expanded the search platform now publicly available for ...
(Date:7/25/2014)... Ohio (PRWEB) July 25, 2014 Consuming ... foods? How to know? , Read the labels! , ... and determine how it relates to health during a ... p.m. Aug. 1 at Humility House, 755 Ohltown Road, ... will lead an informational discussion and answer questions. ...
Breaking Medicine News(10 mins):Health News:Studio B Dental Improves Patient Smiles with All-on-Four Dental Implants 2Health News:Banish My Bumps Pdf Review Exposes Angela Steinberg's Keratosis Pilaris Treatment Plan – Vkool.com 2Health News:Banish My Bumps Pdf Review Exposes Angela Steinberg's Keratosis Pilaris Treatment Plan – Vkool.com 3Health News:PersonalInjurySolicitorsIreland.com Announces the Launch of their New Company and Website 2Health News:SR22 Insurance for High Risk Motorists Added to Local Quotes System at Insurer Website Online 2Health News:Learn to Decipher Food Labels at Humility House 2
... had developed new technology to use transistors in devices ... ,The biosensor technology was developed by a ... Science and Technology. ,"We proved that transistors ... for devices that convert biological responses into electrical signals," ...
... First Lady of the United States, Laura Bush arrived in the ... Africa tour to bolster the US government's anti AIDS and malaria ... President Abdoulaye Wade's wife Viviane. ,From Senegal she is ... a five-day long trip to the continent which will also focus ...
... study published on bmj.com today (Tuesday 26 June) ... patients with well-controlled, non-insulin dependent (type 2) diabetes. ... the American Diabetes Association Conference, suggests that current ... reviewed. ,Non-insulin dependent (type 2) diabetes ...
... observed as the National Testing Day in the US. ... produced by the National Association of People with AIDS ... HIV counseling and testing. ,The Centers for ... 280,000 people nationwide are HIV-positive but are unaware of ...
... celebrating annual Monsoon festival, which marks San Joao, the feast ... a legacy Goans have inherited from the Portuguese, who ruled ... ,During the celebrations, Goans jumped into rivers, ponds and wells ... celebrated with much traditional fervour. ,At Loutulim in ...
... for Evolutionary Anthropology, Leipzig, Germany, have investigated evidence of ... about altruism are often based on the assumption that ... human version differs from that of other animals in ... colleagues have found evidence that chimpanzees act altruistically toward ...
Cached Medicine News:Health News:Questions Over Value of Glucose Monitoring for Non-insulin Using Diabetes Patients 2Health News:US Officials Urge Testing for HIV as Health Crisis Intensifies 2Health News:US Officials Urge Testing for HIV as Health Crisis Intensifies 3Health News:Goans Celebrate Monsoon Festival 2